CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival. - Wikidata - awgldk - TriplyDB

CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival.

CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival.

http://www.wikidata.org/entity/Q34673098

about

Increased Heterologous Protein Expression in Drosophila S2 Cells for Massive Production of Immune Ligands/Receptors and Structural Analysis of Human HVEM Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patients CD160 is essential for NK-mediated IFN-γ production New insights into T-cell cosignaling in allograft rejection and survival.T Cells Going Innate.Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice.Associations between HVEM/LIGHT/BTLA/CD160 polymorphisms and the occurrence of antibody-mediate rejection in renal transplant recipients.Expansion of CD4 phenotype among CD160 receptor-expressing lymphocytes in murine pregnancy.Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.

P2860

Q27701603-407FB61A-6D0B-4C75-8E53-73D30DF568BC Q34639457-AF4E94BA-2E14-43F6-A2EC-05C1908C9361 Q35161483-539ABEAF-B1E6-44B2-8040-A8F5AB67C87F Q38309285-110F9603-6302-4F9E-8D38-BC569929F09D Q38893279-BA470231-AC15-4360-A07C-5BA93F4B3A95 Q41696303-E58721D7-684F-4617-B16E-376D8732487C Q47094450-870264B1-7F14-40CD-8494-C8CD6DD77C73 Q48331912-D2C807B9-3852-4A6A-AE51-4D63C81C3480 Q50791583-3521DF4A-92FF-4794-971C-37D2718E4FF2

P2860

CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival.

http://www.wikidata.org/entity/Q34673098

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

CD160Ig fusion protein targets ...... d prolongs allograft survival.

@ast

CD160Ig fusion protein targets ...... d prolongs allograft survival.

@en

CD160Ig fusion protein targets ...... d prolongs allograft survival.

@nl

type

label

CD160Ig fusion protein targets ...... d prolongs allograft survival.

@ast

CD160Ig fusion protein targets ...... d prolongs allograft survival.

@en

CD160Ig fusion protein targets ...... d prolongs allograft survival.

@nl

prefLabel

CD160Ig fusion protein targets ...... d prolongs allograft survival.

@ast

CD160Ig fusion protein targets ...... d prolongs allograft survival.

@en

CD160Ig fusion protein targets ...... d prolongs allograft survival.

@nl

P1433

Q34673098-EF7D52EB-70AD-4389-AAD8-4BC54737FB52

P1476

Q34673098-47A6552B-527B-41AF-9660-D98E764B68FA

P2093

Q34673098-0D1F52B3-CB34-45A8-BFC9-6E765548B2A5

Q34673098-458F968B-E794-4BFF-AADD-F260A579F067

Q34673098-6B57DAB4-4087-4FB4-B7CF-FD178F8BA8F5

Q34673098-864ED64C-2283-488C-ACC4-BA8D1E038A89

Q34673098-A6293B1C-FA72-4DDE-A427-1B1FF774A306

Q34673098-B79C0B4E-8937-441D-B8F2-C4DA3F052CEF

Q34673098-E2B62C38-ED83-4078-B3BB-803B1AB2AC65

Q34673098-FF4B0DEA-69F7-4D7A-AEB9-9AB919CA47CD

P2860

Q34673098-02912F52-A074-4AE5-88DA-3A56BA0A62FA

Q34673098-0DAACF43-69D9-44E7-9D29-F6F75B66D239

Q34673098-14D34947-B0F1-470F-B57E-2BC3C1126BD2

Q34673098-1DEA9766-91C5-452C-AAE4-E33B91BE04C7

Q34673098-216015FA-F938-4D39-8A24-5EE17A293332

Q34673098-289F19A0-0B52-4285-881E-2D7BA1C54A4A

Q34673098-2B68804C-B6C9-465D-B728-D47951553F89

Q34673098-3026EB60-C532-4414-A158-29C09B6E38F8

Q34673098-32B3FCEE-3098-49A8-82DC-EA892863ED9F

Q34673098-38100ED4-14D8-47BE-B4EF-EF1E410E387A

P304

Q34673098-EDA0A05D-FB11-4B1F-9513-C399CE966EEF

P31

Q34673098-144C3892-8D6C-43CA-839D-AFFD5C490BE5

P356

Q34673098-DE250A3B-FE28-439F-BF34-44922C963A99

P407

Q34673098-4E2F9969-C7CD-4ED3-8ED7-D0E3AD0D7964

P433

Q34673098-2D971F1B-AD8B-4386-BDCF-730CCFBFFE61

P478

Q34673098-CE29B8A5-800E-41B6-AEB5-F4C1D2A1CD2C

P50

Q34673098-507257A1-9E3E-4FC2-A7A4-8705920C06F9

Q34673098-D3FDB879-87C1-4CEE-BB83-B2A1D3B006E4

P577

Q34673098-4B7A5308-5A5A-4D42-B008-86E296C4A07E

P5875

Q34673098-20B566A1-7A7A-4B25-9BC9-67637DC2DAE9

P698

Q34673098-8350628B-7842-4CB5-8886-53F0152732AE

P932

Q34673098-2AD9CCC5-1310-4A69-8563-055DDD38EFFF

P356

JOURNAL.PONE.0060391

P1433

P1476

CD160Ig fusion protein targets ...... d prolongs allograft survival.

@en

P2093

Andrea Vergani

http://www.w3.org/2001/XMLSchema#string

Antje Habicht

http://www.w3.org/2001/XMLSchema#string

Baogong Zhu

http://www.w3.org/2001/XMLSchema#string

Gordon J Freeman

http://www.w3.org/2001/XMLSchema#string

Michael Clarkson

http://www.w3.org/2001/XMLSchema#string

Mohamed H Sayegh

http://www.w3.org/2001/XMLSchema#string

Mohammed Javeed I Ansari

http://www.w3.org/2001/XMLSchema#string

Takuya Ueno

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells

Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset

Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes

Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.

BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression

A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity

Restoring function in exhausted CD8 T cells during chronic viral infection

Characterization of mouse and human B7-H3 genes

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

Homeostatic proliferation is a barrier to transplantation tolerance.

P304

e60391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0060391

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Francesca D'Addio

P577

2013-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236207573

http://www.w3.org/2001/XMLSchema#string

P698

23593209

http://www.w3.org/2001/XMLSchema#string

P932

3617215

http://www.w3.org/2001/XMLSchema#string